Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Smith Rachel Insider Profile
4 Followers
Smith Rachel, VP of R&D at Capricor Therapeutics, holds 18.50K shares in Capricor Therapeutics (Ticker: CAPR).
Smith Rachel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
VP of R&D
Roles that Smith Rachel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Smith Rachel
Smith Rachel's Trading History
List of latest transactions for each holding click on a transaction to see Smith Rachel's performance on stock
You May Also Like
Smith Rachel insider profile FAQ
What is the percentage of profitable transactions made by Smith Rachel?
The percentage of profitable transactions made by Smith Rachel is ―.
What is the average return per transaction made by Smith Rachel?
The average return per transaction made by Smith Rachel is ―.
What stocks does Smith Rachel hold?
Smith Rachel holds: CAPR stocks.
What was Smith Rachel’s latest transaction?
Smith Rachel latest transaction was an Uninformative Sell of $3.32K.
What was Smith Rachel's most profitable transaction?
Smith Rachel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Smith Rachel's role in Capricor Therapeutics?
Smith Rachel's role in Capricor Therapeutics is VP of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.